La Jolla Pharmaceutical Company Announces Fourth-Quarter And Full-Year 2013 Financial Results And Highlights Recent Corporate Progress

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

La Jolla Pharmaceutical Company (NASDAQ: LJPC) (the “Company” or “La Jolla”), a leader in the development of therapeutics targeting significant unmet life-threatening diseases, announces fourth-quarter and full-year 2014 financial results and highlights recent corporate progress.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC